Found 55 matching trials
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension PHASE4 In patients naive to treatment or after a 2-week washout period for patient...
Show More Location
Multiple Locations
Learn More & Join Trial
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination PHASE4 To compare the antihypertensive efficacy of the combination irbesartan/hydr...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension PHASE3 The purpose of this study is to assess the potential of using valsartan/HCT...
Show More Location
Novartis Pharmaceuticals
Learn More & Join Trial
Antihypertensive Response to Losartan and Genetic Polymorphisms NA The purpose of this study is to evaluate the antihypertensive response of t...
Show More Location
Multiple Locations
Learn More & Join Trial
Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension PHASE4 The purpose of the study is to evaluate the blood pressure lowering effect ...
Show More Location
Novartis Pharmaceuticals
Learn More & Join Trial
Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) PHASE3 The purpose of this study is to evaluate antihypertensive (lowering blood p...
Show More Location
Multiple Locations
Learn More & Join Trial
Candesartan Effect in Second Stage Arterial Hypertension PHASE4 To compare the changes in mean sitting DBP from baseline after 4 weeks of t...
Show More Learn More & Join Trial
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension PHASE4 This is a double-blind study to evaluate the reduction in systolic blood pr...
Show More Location
Novartis Pharmaceuticals
Learn More & Join Trial
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy PHASE4 The population for this current study will include stage 1 and stage 2 hype...
Show More Location
Multiple Locations
Learn More & Join Trial
Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension PHASE3 The primary objective of this study was to assess the anti-hypertensive eff...
Show More Location
Multiple Locations
Learn More & Join Trial